• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

人抗鼠抗体对接受鼠单克隆抗体OC 125放射免疫治疗或免疫闪烁显像的卵巢癌患者CA 125水平的影响。

Influence of human antimurine antibody on CA 125 levels in patients with ovarian cancer undergoing radioimmunotherapy or immunoscintigraphy with murine monoclonal antibody OC 125.

作者信息

Muto M G, Lepisto E M, Van den Abbeele A D, Knapp R C, Kassis A I

机构信息

Department of Obstetrics and Gynecology, Harvard Medical School, Boston, MA.

出版信息

Am J Obstet Gynecol. 1989 Nov;161(5):1206-12. doi: 10.1016/0002-9378(89)90667-4.

DOI:10.1016/0002-9378(89)90667-4
PMID:2686446
Abstract

Human antimurine antibody responses interfere with CA 125 antigen determinations by crosslinking the murine antiovarian carcinoma monoclonal antibody OC 125 with the second murine radiolabeled antibody used in the CA 125 radioimmunoassay. Serial CA 125 levels in 22 patients with epithelial ovarian carcinoma undergoing either radioimmunotherapy or radioimmunoscintigraphy with iodine 131-labeled F(ab')2 fragments of OC 125 were followed up for up to 96 weeks after infusion. Fourteen radioimmunoscintigraphy patients received 131I-labeled monoclonal antibody by the intraperitoneal (n = 5) or intravenous (n = 9) route: 10 of 14 had sera drawn at appropriate time points for human antimurine antibody detection; 8 of 10 had 1.3- to 363-fold increases in CA 125; 4 of 8 had detectable human antimurine antibody (18.5 to 22 and 575 to 36 micrograms/ml). Eight radioimmunotherapy patients received 131I-labeled monoclonal antibody by the intraperitoneal route: 8 of 8 displayed an apparent 4.8- to 3725-fold increase in CA 125 levels within 7 to 42 days after monoclonal antibody infusion; 6 of 8 had detectable human antimurine antibody (13 to 4 and 319 to 31 micrograms/ml). Adsorption of immunoglobulin G resulted in a 21% to 98% reduction in CA 125 antigen levels in 4 of 4 patients tested. In patients with demonstrable human antimurine antibody, CA 125 antigen levels obtained by the clinical CA 125 radioimmunoassay are spuriously elevated.

摘要

人抗鼠抗体反应通过使鼠抗卵巢癌单克隆抗体OC 125与CA 125放射免疫分析中使用的第二种鼠放射性标记抗体交联,干扰CA 125抗原的测定。对22例接受131碘标记的OC 125 F(ab')2片段进行放射免疫治疗或放射免疫闪烁成像的上皮性卵巢癌患者,在输注后长达96周内随访其CA 125水平。14例放射免疫闪烁成像患者通过腹腔内(n = 5)或静脉内(n = 9)途径接受131I标记的单克隆抗体:14例中有10例在适当时间点采集血清检测人抗鼠抗体;10例中有8例CA 125升高1.3至363倍;8例中有4例可检测到人抗鼠抗体(18.5至22和575至36微克/毫升)。8例放射免疫治疗患者通过腹腔内途径接受131I标记的单克隆抗体:8例中有8例在单克隆抗体输注后7至42天内CA 125水平明显升高4.8至3725倍;8例中有6例可检测到人抗鼠抗体(13至4和319至31微克/毫升)。在4例检测的患者中,免疫球蛋白G的吸附导致CA 125抗原水平降低21%至98%。在可检测到人抗鼠抗体的患者中,临床CA 125放射免疫分析获得的CA 125抗原水平会假性升高。

相似文献

1
Influence of human antimurine antibody on CA 125 levels in patients with ovarian cancer undergoing radioimmunotherapy or immunoscintigraphy with murine monoclonal antibody OC 125.人抗鼠抗体对接受鼠单克隆抗体OC 125放射免疫治疗或免疫闪烁显像的卵巢癌患者CA 125水平的影响。
Am J Obstet Gynecol. 1989 Nov;161(5):1206-12. doi: 10.1016/0002-9378(89)90667-4.
2
Influence of circulating antigen on blood pool activity of a radioiodinated monoclonal antibody.循环抗原对放射性碘化单克隆抗体血池活性的影响。
Int J Rad Appl Instrum B. 1988;15(4):431-7. doi: 10.1016/0883-2897(88)90014-1.
3
Human anti-murine antibody responses in ovarian cancer patients undergoing radioimmunotherapy with the murine monoclonal antibody OC-125.接受鼠单克隆抗体OC-125放射免疫治疗的卵巢癌患者的人抗鼠抗体反应
Gynecol Oncol. 1990 Aug;38(2):244-8. doi: 10.1016/0090-8258(90)90049-q.
4
Radioimmunoscintigraphy using monoclonal antibodies to CEA, CA 19-9 and CA 125.使用针对癌胚抗原(CEA)、糖类抗原19-9(CA 19-9)和糖类抗原125(CA 125)的单克隆抗体进行放射免疫闪烁显像。
Int J Biol Markers. 1988 Jul-Sep;3(3):177-84. doi: 10.1177/172460088800300306.
5
Intraperitoneal radioimmunotherapy of refractory ovarian carcinoma utilizing iodine-131-labeled monoclonal antibody OC125.利用碘-131标记的单克隆抗体OC125对难治性卵巢癌进行腹腔内放射免疫治疗。
Gynecol Oncol. 1992 Jun;45(3):265-72. doi: 10.1016/0090-8258(92)90302-y.
6
Immunolymphoscintigraphy and immunoscintigraphy of ovarian and fallopian tube cancer using F(ab')2 fragments of monoclonal antibody OC 125.使用单克隆抗体OC 125的F(ab')2片段对卵巢癌和输卵管癌进行免疫淋巴闪烁显像和免疫闪烁显像。
Cancer Res. 1990 Feb 1;50(3 Suppl):937s-940s.
7
Pharmacokinetics of a radioiodinated monoclonal antibody F(ab')2 fragment in a xenograft model with circulating antigen.放射性碘化单克隆抗体F(ab')2片段在伴有循环抗原的异种移植模型中的药代动力学
Int J Rad Appl Instrum B. 1989;16(4):405-11. doi: 10.1016/0883-2897(89)90108-6.
8
Distribution and pharmacokinetics of radiolabeled monoclonal antibody OC 125 after intravenous and intraperitoneal administration in gynecologic tumors.
Am J Obstet Gynecol. 1988 Oct;159(4):843-8. doi: 10.1016/s0002-9378(88)80150-9.
9
Falsely low results in CA 125 determination due to anti-idiotypic antibodies induced by infusion of [131I]F(ab')2 fragments of the OC125 antibody.由于输注OC125抗体的[131I]F(ab')2片段诱导产生抗独特型抗体,导致CA 125测定结果假性降低。
Eur J Clin Chem Clin Biochem. 1993 May;31(5):323-7. doi: 10.1515/cclm.1993.31.5.323.
10
Radioimmunoscintigraphy of ovarian cancer with 131-iodine labeled OC-125 antibody fragments.
Eur J Nucl Med. 1989;15(1):42-8. doi: 10.1007/BF00253598.

引用本文的文献

1
Effect of circulating antigen on immunoscintigraphy of ovarian cancer patients using anti-CA125 monoclonal antibody.循环抗原对使用抗CA125单克隆抗体的卵巢癌患者免疫闪烁显像的影响。
Jpn J Cancer Res. 1996 Jun;87(6):655-61. doi: 10.1111/j.1349-7006.1996.tb00273.x.
2
False changes in CA 125 levels in ovarian cancer patients after infusion of OC125 fragments for diagnostic and therapeutic purpose.为诊断和治疗目的输注OC125片段后,卵巢癌患者CA 125水平出现假性变化。
Arch Gynecol Obstet. 1994;255(1):9-18. doi: 10.1007/BF02390669.
3
A human/mouse chimeric monoclonal antibody against CA125 for radioimmunoimaging of ovarian cancer.
一种用于卵巢癌放射免疫显像的抗CA125人/鼠嵌合单克隆抗体。
Cancer Immunol Immunother. 1993 Aug;37(3):143-9. doi: 10.1007/BF01525427.
4
Radioimmunoscintigraphy of ovarian tumours with technetium-99m labelled monoclonal antibody-170: first clinical experiences.用锝-99m标记单克隆抗体-170对卵巢肿瘤进行放射免疫闪烁显像:首次临床经验。
Eur J Nucl Med. 1995 Jul;22(7):645-51. doi: 10.1007/BF01254566.
5
Does immunoscintigraphy serve clinical needs effectively? Is there a future for radioimmunotherapy?免疫闪烁显像能否有效满足临床需求?放射免疫疗法是否有未来?
Eur J Nucl Med. 1992;19(3):205-13. doi: 10.1007/BF00173283.